Literature DB >> 18830053

Suppressed production of pro-inflammatory cytokines by LPS-activated macrophages after treatment with Toxoplasma gondii lysate.

Eun-Jung Lee1, Yoo-Mi Heo, Jong-Hak Choi, Hyun-Ouk Song, Jae-Sook Ryu, Myoung-Hee Ahn.   

Abstract

During Toxoplasma gondii infection, macrophages, dendritic cells, and neutrophils are important sources of pro-inflammatory cytokines from the host. To counteract the pro-inflammatory activities, T. gondii is known to have several mechanisms inducing down-regulation of the host immunity. In the present study, we analyzed the production of proand anti-inflammatory cytokines from a human myelomonocytic cell line, THP-1 cells, in response to treatment with T. gondii lysate or lipopolysaccharide (LPS). Treatment of THP-1 cells with LPS induced production of IL-12, TNF-alpha, IL-8, and IL-10. Co-treatment of THP-1 cells with T. gondii lysate inhibited the LPS-induced IL-12, IL-8 and TNF-alpha expression, but increased the level of IL-10 synergistically. IL-12 and IL-10 production was down-regulated by anti-human toll-like receptor (TLR)-2 and TLR4 antibodies. T. gondii lysate triggered nuclear factor (NF)-kappaB-dependent IL-8 expression in HEK293 cells transfected with TLR2. It is suggested that immunosuppression induced by T. gondii lysate treatment might occur via TLR2-mediated NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830053      PMCID: PMC2553329          DOI: 10.3347/kjp.2008.46.3.145

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  28 in total

1.  Cutting edge: identification of c-Rel-dependent and -independent pathways of IL-12 production during infectious and inflammatory stimuli.

Authors:  Nicola Mason; Julio Aliberti; Jorge C Caamano; Hsiou-Chi Liou; Christopher A Hunter
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

2.  Involvement of tumor necrosis factor-alpha during infection of human monocytic cells by Toxoplasma gondii.

Authors:  A Belloni; D Aubert; J E Gomez Marin; R Le Naour; A Bonhomme; M Guenounou; J M Pinon
Journal:  Parasitol Res       Date:  2000-05       Impact factor: 2.289

3.  Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite.

Authors:  M A Campos; I C Almeida; O Takeuchi; S Akira; E P Valente; D O Procópio; L R Travassos; J A Smith; D T Golenbock; R T Gazzinelli
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

4.  Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production.

Authors:  J A Langermans; P H Nibbering; M E Van Vuren-Van Der Hulst; R Van Furth
Journal:  Parasite Immunol       Date:  2001-04       Impact factor: 2.280

5.  Nuclear factor-kappa B plays a major role in the regulation of chemokine expression of HeLa cells in response to Toxoplasma gondii infection.

Authors:  J M Kim; Y K Oh; Y J Kim; S J Cho; M H Ahn; Y J Cho
Journal:  Parasitol Res       Date:  2001-09       Impact factor: 2.289

6.  Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-kappa B.

Authors:  B A Butcher; L Kim; P F Johnson; E Y Denkers
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

7.  TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection.

Authors:  Hye-Seong Mun; Fumie Aosai; Kazumi Norose; Mei Chen; Lian-Xun Piao; Osamu Takeuchi; Shizuo Akira; Hiroshi Ishikura; Akihiko Yano
Journal:  Int Immunol       Date:  2003-09       Impact factor: 4.823

8.  Regulation of tumor necrosis factor alpha and its specific receptors during Toxoplasma gondii infection in human monocytic cells.

Authors:  A Belloni; I Villena; J E Gomez; H Pelloux; A Bonhomme; M Guenounou; J M Pinon; D Aubert
Journal:  Parasitol Res       Date:  2002-10-12       Impact factor: 2.289

9.  Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii.

Authors:  Françoise Debierre-Grockiego; Marco A Campos; Nahid Azzouz; Jörg Schmidt; Ulrike Bieker; Marianne Garcia Resende; Daniel Santos Mansur; Ralf Weingart; Richard R Schmidt; Douglas T Golenbock; Ricardo T Gazzinelli; Ralph T Schwarz
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

Review 10.  Toll-like receptors and their signaling mechanisms.

Authors:  Shizuo Akira; Shintaro Sato
Journal:  Scand J Infect Dis       Date:  2003
View more
  6 in total

1.  Suppressed CD31 expression in sarcoma-180 tumors after injection with Toxoplasma gondii lysate antigen in BALB/c mice.

Authors:  Kyoung-Ho Pyo; Bong-Kwang Jung; Jong-Yil Chai; Eun-Hee Shin
Journal:  Korean J Parasitol       Date:  2010-06-17       Impact factor: 1.341

2.  The GRA15 protein from Toxoplasma gondii enhances host defense responses by activating the interferon stimulator STING.

Authors:  Peiyan Wang; Siji Li; Yingchi Zhao; Baohuan Zhang; Yunfei Li; Shengde Liu; Hongqiang Du; Lili Cao; Meiling Ou; Xiaohong Ye; Peng Li; Xiang Gao; Penghua Wang; Chunxia Jing; Feng Shao; Guang Yang; Fuping You
Journal:  J Biol Chem       Date:  2019-08-15       Impact factor: 5.157

3.  Proinflammatory cytokine and nitric oxide production by human macrophages stimulated with Trichomonas vaginalis.

Authors:  Ik-Hwan Han; Sung Young Goo; Soon-Jung Park; Se-Jin Hwang; Yong-Seok Kim; Michael Sungwoo Yang; Myoung-Hee Ahn; Jae-Sook Ryu
Journal:  Korean J Parasitol       Date:  2009-08-28       Impact factor: 1.341

4.  Suppression of CD4 T-Cells in the spleen of mice infected with Toxoplasma gondii KI-1 tachyzoites.

Authors:  Won-Hee Kim; Eun-Hee Shin; Jae-Lip Kim; Seung-Young Yu; Bong-Kwang Jung; Jong-Yil Chai
Journal:  Korean J Parasitol       Date:  2010-12-16       Impact factor: 1.341

5.  GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition.

Authors:  Dolores Limongi; Sara Baldelli; Paola Checconi; Maria Elena Marcocci; Giovanna De Chiara; Alessandra Fraternale; Mauro Magnani; Maria Rosa Ciriolo; Anna Teresa Palamara
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

6.  Possible role of TLR4 and TLR9 SNPs in protection against congenital toxoplasmosis.

Authors:  W Wujcicka; Z Gaj; J Wilczyński; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-09       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.